Financial intelligence for Asia's healthcare markets
Remember me:

HIAS: Telemedicine does not replace doctors

Despite all of the conversations about patient-centric technology, James Kilmister, development director at Civica, and chairman of the panel on “How tech and digitalisation can enhance operational efficiency and patient outcomes” cut straight to the heart of the matter. “How do you get it into organisations?” he asked.

Ronald Ling, chief executive, ConnectedHealth, said that technology needed to be both consumer and doctor facing. There has been a huge take-off of digital health in the US, indeed it is one of the fastest venture funded sectors because it is supported by insurers. “What the payer says the providers have to follow,” he said. Areas where this has resulted in cost savings are getting traction because of an active payer system. But, he emphasised: “Healthcare is a local game, it has to be significantly adapted to local markets”.

Peng Chung Mien, chief executive of The Farrer Park Company, explained how it has worked in Singapore. In one sense, he said, it was easy for him because he was a startup with a clean slate. “Business processes have been challenging,” he admitted. He specifically mentioned adoption by doctors. Older ones are happy with pen and paper, while it is easier to convince the younger ones. The new National Electronic Health System in Singapore is helping. “Doctors realise that it is top down,” he said.

For Michael Fernandes, partner at LeapFrog Investments, the difficulty is how to deliver healthcare in spaces that are not urban. “The biggest challenge is to connect the providers with the patients,” he said. He pointed out that although telemedecine has existed for a long time, it has often been impractical. It has been difficult to do bloodwork, for example and often results in the teledoctor recommending a trip to a conventional physician.

But the issue remains of how can organisations overcome a well-known aversion towards technology in older patients. “You have to design your products well,” said Ling. If they are to succeed, products in Asia have to recognise local conditions. There is the recognition that people get help from helpers and family members. Technology needs to recognise that. Above all, he concluded is the need to recognise that “technology will never replace the human, but it will improve the productivity of doctors.”

Posted on: 15/05/2018 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.